The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection

SEER Cancer Statistics Review, 1975-2003

2006 • 11,387 citations

1969 Cancer Facts and Figures

1968 • 8,880 citations

SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD

2011 • 2,409 citations

Molecular imaging in living subjects: seeing fundamental biological processes in a new light

2003 • 2,194 citations

Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations

2002 • 1,448 citations

Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation

2002 • 1,229 citations

The case for early detection

2003 • 1,099 citations

Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship

2007 • 1,074 citations

The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome

2006 • 871 citations

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

2009 • 794 citations

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

2008 • 782 citations

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

2005 • 682 citations

Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada

2006 • 663 citations

Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a <EMPH TYPE="ITAL">BRCA1</EMPH> or <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation

2006 • 583 citations

Screening for ovarian cancer: a pilot randomised controlled trial

1999 • 563 citations

Clinicopathologic Features of <EMPH TYPE="ITAL">BRCA</EMPH>-Linked and Sporadic Ovarian Cancer

2000 • 537 citations

Primary Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for Ovarian Cancer Risk Reduction

2007 • 472 citations

Serum protein markers for early detection of ovarian cancer

2005 • 437 citations

Improved survival in women with BRCA‐associated ovarian carcinoma

2003 • 430 citations

Diagnostic Markers for Early Detection of Ovarian Cancer

2008 • 409 citations

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers

2005 • 372 citations

Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy

2004 • 358 citations

Occult Carcinoma in Prophylactic Oophorectomy Specimens

2001 • 330 citations

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

2006 • 321 citations

Pathologic Findings in Prophylactic Oophorectomy Specimens in High-Risk Women

2002 • 297 citations

Hysterectomy surveillance in the United States, 1997 through 2005.

2008 • 293 citations

US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in Mice

2008 • 293 citations

Microscopic Benign and Invasive Malignant Neoplasms and a Cancer-Prone Phenotype in Prophylactic Oophorectomies

1996 • 266 citations

A randomized study of screening for ovarian cancer: a multicenter study in Japan

2007 • 263 citations

Histologic Subtypes of Ovarian Carcinoma

2008 • 262 citations

The Natural History of Invasive Breast Cancers Detected by Screening Mammography

2008 • 255 citations

Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial

2009 • 249 citations

Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers

2004 • 247 citations

Early de novo ovarian carcinoma. A study of fourteen cases

1994 • 224 citations

PREVALENCE, INCIDENCE AND DURATION

1980 • 221 citations

Ovarian cancer screening with annual transvaginal sonography

2007 • 209 citations

Occult Cancer of the Fallopian Tube in BRCA-1 Germline Mutation Carriers at Prophylactic Oophorectomy: A Case for Recommending Hysterectomy at Surgical Prophylaxis

2001 • 195 citations

Occult Ovarian Tumors in Women With BRCA1 or BRCA2 Mutations Undergoing Prophylactic Oophorectomy

2000 • 184 citations

Screening for Familial Ovarian Cancer: Failure of Current Protocols to Detect Ovarian Cancer at an Early Stage According to the International Federation of Gynecology and Obstetrics System

2005 • 154 citations

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study

2007 • 145 citations

Advances in the Recognition of Tubal Intraepithelial Carcinoma

2006 • 144 citations

Biology of Epithelial Ovarian Cancer: Implications for Screening Women at High Genetic Risk

2004 • 136 citations

Incidental Carcinomas in Prophylactic Specimens in BRCA1 and BRCA2 Germ-line Mutation Carriers, With Emphasis on Fallopian Tube Lesions

2006 • 131 citations

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up

2004 • 130 citations

Histopathologic Features of Genetically Determined Ovarian Cancer

2002 • 118 citations

Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high‐risk and population risk women is ineffective

2007 • 116 citations

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy

2006 • 103 citations

Ovarian dysplasia in prophylactic oophorectomy specimens

1999 • 103 citations

Cancer Incidence in a Population of Jewish Women at Risk of Ovarian Cancer

2002 • 94 citations

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer

2005 • 91 citations

Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach

2003 • 88 citations

Histopathology, FIGO Stage, and BRCA Mutation Status of Ovarian Cancers from the Gilda Radner Familial Ovarian Cancer Registry

2003 • 81 citations

Cancer Screening: A Mathematical Model Relating Secreted Blood Biomarker Levels to Tumor Sizes

2008 • 79 citations

Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study

2006 • 62 citations

Prophylactic salpingo‐oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation

2007 • 52 citations

Results from an ultrasound‐based familial ovarian cancer screening clinic: a 10‐year observational study

2003 • 51 citations

Validation and Characterization of Human Kallikrein 11 as a Serum Marker for Diagnosis of Ovarian Carcinoma

2007 • 43 citations

Prospectively detected cancer in familial breast/ovarian cancer screening

1999 • 43 citations

Prospectively detected cancer in familial breast/ovarian cancer screening

1999 • 33 citations

Ovarian Cancer Screening in Women With a Family History of Breast or Ovarian Cancer

2006 • 27 citations